首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis.
【24h】

Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis.

机译:鼻咽培养在普通感冒或急性鼻窦炎患者的抗生素处方中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present study was to assess the hypothesis that, when present in nasopharyngeal secretions, Streptococcus pneumoniae. Haemophilus influenzae, and Moraxella catarrhalis play a pathogenic role early in the course of an upper respiratory tract infection. Adults with a clinical diagnosis of acute sinusitis or common cold were enrolled. Participants were randomly assigned in a double-blind manner to receive azithromycin 500 mg daily or placebo for 3 days. The effect of treatment on symptom evolution in the predefined subset of patients with Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis in their nasopharyngeal secretions was assessed. Of 265 patients enrolled, 132 received placebo and 133 azithromycin. Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis was identified in nasopharyngeal secretions of 77 patients (29%). In this predefined subgroup of patients with Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis, resolution of symptoms by day 7 occurred in 73% of those treated with azithromycin compared with 47% of those who received placebo (P=0.007). The median time before resolution of symptoms was 5 days in the azithromycin group compared to 7 days in the placebo group. Respiratory complications requiring antibiotic treatment occurred in 19% of patients in the placebo group and in 3% of the azithromycin group (P=0.025). In the remaining 188 patients without Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis, resolution of symptoms by day 7 was similar in both groups (69% in the placebo group vs. 64% in the azithromycin group [P=0.75]). Antibiotic treatment is of clinical benefit for patients with acute sinusitis or common cold when Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis is present in nasopharyngeal secretions. This observation provides new insights into the pathogenic role of these bacteria in the early stage of the common cold.
机译:本研究的目的是评估假说,即存在于鼻咽分泌物中的是肺炎链球菌。流感嗜血杆菌和卡他莫拉菌在上呼吸道感染的早期阶段起着致病作用。纳入临床诊断为急性鼻窦炎或普通感冒的成年人。参加者以双盲方式随机分配,每天接受500 mg阿奇霉素或安慰剂治疗3天。评估了治疗对预定义的肺炎链球菌,流感嗜血杆菌或鼻咽分泌物莫拉氏菌患者的症状演变的影响。在265名患者中,有132名接受了安慰剂和133名阿奇霉素。在77例患者的鼻咽分泌物中发现了肺炎链球菌,流感嗜血杆菌或卡他莫拉菌(29%)。在这个预先确定的亚组的肺炎链球菌,流感嗜血杆菌或卡他莫拉菌患者中,接受阿奇霉素治疗的患者中有73%的患者在第7天症状缓解,而接受安慰剂的患者为47%(P = 0.007)。阿奇霉素组症状缓解前的中位时间为5天,而安慰剂组为7天。安慰剂组和阿奇霉素组分别有19%和3%的患者发生需要抗生素治疗的呼吸系统并发症(P = 0.025)。在其余188例无肺炎链球菌,流感嗜血杆菌或卡他莫拉菌的患者中,两组的症状缓解在第7天相似(安慰剂组为69%,阿奇霉素组为64%[P = 0.75])。当鼻咽分泌物中存在肺炎链球菌,流感嗜血杆菌或卡他莫拉菌时,抗生素治疗对急性鼻窦炎或普通感冒患者具有临床益处。该观察结果为这些细菌在普通感冒初期的致病作用提供了新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号